Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1128.9000 33.20 (3.03%)
NSE Sep 18, 2025 15:31 PM
Volume: 1.8M
 

logo
Aurobindo Pharma Ltd.
13 Nov 2018
1128.90
3.03%
buy
Results Update: Aurobindo Pharma Ltd.
by HDFC Securities
HDFC Securities
Aurobindo Pharma Ltd Q2FY19 results Comment Revenue grew by 11.61% to Rs. 4667.12 Cr in Q2FY19 when compared to the previous quarter. Also, it increased by 7.19% when compared with Q2FY18.
 
Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Market closes higher, Ugro Capital gets RBI nod to acquire Profectus Capital
Trendlyne Marketwatch | 18 Sep 2025, 04:03PM
Bull run fizzles out: Multibagger count in Indian equities falls
The Baseline | 18 Sep 2025, 03:38PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020